TopFunds

Becton Dickinson

NYSE: BDX

Stock price

180.94 USD

(-9.94%) 5 years

Health Care EquipmentMedical - Instruments & Supplies

Insider Transactions

5Y price score: (13)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -9.94%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
26-aug.-26Sale(165)188.5(31,101)19,720Feld Michaelofficer: EVP, Chief Revenue Officerlink
13-aug.-26Sale(4,152)185.0(768,120)110,163Polen Thomas E Jrdirector, officer: Chairman, CEO and Presidentlink
11-aug.-26Sale(2,438)180.8(440,888)14,856Goette Rolandofficer: EVP and President, EMEAlink
06-aug.-26Award189--595Huffines Robert Lutherdirectorlink
06-aug.-26Award94--3,810Byington Carrie Ldirectorlink
27-jul.-26Sale(75)157.1(11,785)20,934Feld Michaelofficer: EVP, Chief Revenue Officerlink
01-jul.-26Award14,342--43,294Muhsin Bilalofficer: EVP & President Connected Carelink
26-jun.-26Sale(75)152.8(11,460)21,009Feld Michaelofficer: EVP, Chief Revenue Officerlink
24-jun.-26Sale(1,100)145.7(160,226)13,172Garrison Michael Davidofficer: EVP & Pres Med.Essntl&BioPharmlink
10-jun.-26Sale(1,100)151.5(166,628)14,272Garrison Michael Davidofficer: EVP & Pres Med.Essntl&BioPharmlink

127.5

52-week range

193.0

180.94

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

5.1 %

Dividend Yield TTM

2.2 %

Market cap $

$ 49,856

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

54.5

Price / Book TTM

2

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

(106.5)

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

24.5 %

(2.6) %

54.1 %

Free cash flow per share growth

(48.9) %

(3.8) %

76.1 %

Earnings per share growth

(31.5) %

115.1 %

74 %

Dividends

Previous dividend:1.05 per share, Paid, Ex-div date Jun 09, 2026
Next dividend:1.05 per share, Declared, Ex-div date Sep 09, 2026

Analyst ratings

Price Target Low

159

Price Target High

210

Price Target Median

190

Buy

16

Hold

17

Sell

1

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
3.4
4.5
4.6
0.6
3.9
2.7
6.9
5.9
4.9
5.9
5.8
5.7%
5.9
6.2
6.5
6.8
7.1
7
02FCF per share
5.3
8.5
8.2
7.4
8.6
9.7
11.7
5.8
7.3
10.6
9.3
5.8%
12.2
12.9
13.6
14.4
15.2
15.1
03Dividends per share
Help
Adjusted for splitsLearn more
1.8
2
2.2
2.3
2.4
2.4
2.5
2.7
2.9
3.2
3.5
6.6%
-
-
-
-
-
-
04Dividends payout, %
69.8%
57.6%
61.6%
298.1%
79.8%
117.4%
50.1%
60.8%
75.1%
64.5%
71.3%
0.2%
-
-
-
-
-
-
05Revenue
$ 10,282
$ 12,483
$ 12,093
$ 15,983
$ 17,290
$ 16,074
$ 19,131
$ 18,870
$ 19,372
$ 20,178
$ 21,839
7.8%
$ 23,548
$ 25,390
$ 27,377
$ 29,519
$ 31,828
$ 32,783
06ㅤ% Change
-
21.4%
(3.1)%
32.2%
8.2%
(7)%
19%
(1.4)%
2.7%
4.2%
8.2%
7.8%
7.8%
7.8%
7.8%
7.8%
7.8%
7.8%
07Net Income
695
976
1,100
311
1,233
874
2,092
1,779
1,484
1,705
1,678
9.2%
1,763
1,901
2,049
2,210
2,383
2,454
08ㅤ% Margin
6.8%
7.8%
9.1%
2%
7.1%
5.4%
10.9%
9.4%
7.7%
8.5%
7.7%
7.5% A
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
09CFO
1,729
2,559
2,550
2,865
3,330
3,539
4,647
2,633
2,989
3,798
3,430
7.1%
4,406
4,750
5,122
5,523
5,955
6,134
10ㅤ% Of revenue
16.8%
20.5%
21.1%
17.9%
19.3%
22%
24.3%
14%
15.4%
18.8%
15.7%
18.7% A
18.7%
18.7%
18.7%
18.7%
18.7%
18.7%
11CAPEX
(633)
(718)
(727)
(895)
(957)
(810)
(1,231)
(973)
(874)
(725)
(760)
1.9%
(774)
(788.3)
(802.9)
(817.7)
(832.8)
(848.1)
12ㅤ% Change
-
13.4%
1.3%
23.1%
6.9%
(15.4)%
52%
(21)%
(10.2)%
(17.1)%
4.8%
1.9% A
1.9%
1.9%
1.9%
1.9%
1.9%
1.9%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
1,096
1,841
1,823
1,970
2,373
2,729
3,416
1,660
2,115
3,073
2,670
9.3%
3,632
3,962
4,319
4,705
5,122
5,285
14Total assets
26,820
25,586
37,734
53,904
51,842
54,012
53,880
52,934
52,780
57,286
55,325
7.5%
59,480
63,946
68,748
73,911
79,461
85,428
15ㅤ% Change
-
(4.6)%
47.5%
42.9%
(3.8)%
4.2%
(0.2)%
(1.8)%
(0.3)%
8.5%
(3.4)%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
7.5%
16Total liabilities
19,313
17,952
24,786
32,910
30,683
30,247
30,203
27,652
26,983
31,397
29,936
4.5%
32,184
34,601
37,199
39,993
42,996
46,224
17ㅤ% Of assets
72%
70.2%
65.7%
61.1%
59.2%
56%
56.1%
52.2%
51.1%
54.8%
54.1%
54.1% A
54.1%
54.1%
54.1%
54.1%
54.1%
54.1%
18Shareholders Equity
7,507
7,634
12,948
20,994
21,159
23,765
23,677
25,282
25,797
25,889
25,389
13%
27,296
29,345
31,549
33,918
36,465
39,203
19Net Debt
11,398
10,010
4,691
20,355
18,854
15,105
16,032
15,792
15,343
19,730
18,330
4.9%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
207,509
217,536
223,588
264,621
274,775
282,402
292,089
287,364
288,392
291,009
287,118
3.3%
296,594
306,383
316,495
326,941
337,732
348,879
21ㅤ% Change
-
4.8%
2.8%
18.4%
3.8%
2.8%
3.4%
(1.6)%
0.4%
0.9%
(1.3)%
3.3%
3.3%
3.3%
3.3%
3.3%
3.3%
3.3%
22ROA
2.6%
3.8%
2.9%
0.6%
2.4%
1.6%
3.9%
3.4%
2.8%
3%
3%
-
3%
3%
3%
3%
3%
2.9%
23ROE
9.3%
12.8%
8.5%
1.5%
5.8%
3.7%
8.8%
7%
5.8%
6.6%
6.6%
-
6.5%
6.5%
6.5%
6.5%
6.5%
6.3%
24Interest coverage
2.9
3.7
2.9
2.1
2.8
1.7
4.8
5.7
4.7
4.5
4.2
-
-
-
-
-
-
-
25Dividend Yield
2.4%
1.9%
2.1%
1.8%
1.9%
2.1%
1.9%
2.2%
1.9%
2%
2.8%
-
-
-
-
-
-
-
26P/E Ratio
29.7
30
32
327.1
49
64.9
27.2
29.5
40.9
32.2
25.2
-
-
-
-
-
-
-
27Stock price range
87-118
101-139
125-158
149-201
161-203
154-219
174-202
175-217
172-223
174-210
130-196
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
20,608
29,321
32,905
52,389
52,374
49,785
54,542
49,927
58,187
54,922
42,175
7.4%
44,769
51,078
58,019
65,654
74,053
-
29FCF Yield
5.3%
6.3%
5.5%
3.8%
4.5%
5.5%
6.3%
3.3%
3.6%
5.6%
6.3%
1.8%
8.1%
7.8%
7.4%
7.2%
6.9%
-
30Average stock price
102.6
120.3
141.3
174.9
181.9
186.6
188.2
195.9
197.3
192.1
162.8
4.7%
150.9
166.7
183.3
200.8
219.3
-
31 CEO
TJ
Thomas E. Polen Jr.